Disparities in primary pancreatic adenocarcinoma survival by Medicaid-status: A national population-based risk analysis
European Journal of Surgical Oncology · 2023-07 · 49 (7) · 1242-1249
DOI: 10.1016/j.ejso.2023.02.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Surgical Oncology, 2023-07. Verfasst von Arjun Ganga und 7 weiteren Autor:innen. Beteiligte Einrichtung: Roger Williams Medical Center, Division of Surgical Oncology, Providence, RI, USA. Hauptthemen laut MEDLINE: Adenocarcinoma, Pancreatic Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Pancreatic adenocarcinoma (PAC) has one of the highest mortality rates among all malignancies. While previous research has analyzed socioeconomic factors' effect on PAC survival, outcomes of Medicaid patients are understudied. METHODS: Using the SEER-Medicaid database, we studied non-elderly, adult patients with primary PAC diagnosed between 2006 and 2013. Five-year disease-specific survival analysis was performed using the Kaplan-Meier method and adjusted analysis using Cox proportional-hazards regression. RESULTS: Among 15,549 patients (1799 Medicaid, 13,750 non-Medicaid), Medicaid patients were less likely to receive surgery (p < .001) and more likely to be non-White (p < .001). The 5-year survival of non-Medicaid patients (8.13%, 274 days [270-280]) was significantly higher than that of Medicaid patients (4.97%, 152 days, [151-182], p < .001). Among Medicaid patients, those in high poverty areas had significantly lower survival rates (152 days [122-154]) than those in medium poverty areas (182 days [157-213], p = .008). However, non-White (152 days [150-182]) and White Medicaid patients (152 days [150-182]) had similar survival (p = .812). On adjusted analysis, Medicaid patients were still associated with a significantly higher risk of mortality (aHR 1.33 [1.26-1.41], p < .0001) compared to non-Medicaid patients. Unmarried status and rurality were associated with a higher risk of mortality (p < .001). DISCUSSION: Medicaid enrollment prior to PAC diagnosis was generally associated with a higher risk of disease-specific mortality. While there was no difference in the survival between White and non-White Medicaid patients, Medicaid patients living in high poverty areas were shown to be associated with poor survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Roger Williams Medical Center, Division of Surgical Oncology, Providence, RI, USA.
- Massachusetts Institute of Technology, Department of Computer Science, Cambridge, MA, USA.
- Brown University, Department of Computer Science, Providence, RI, USA.
- Baylor College of Medicine, Department of Medicine, Houston, TX, USA.
- University of Virginia School of Medicine, Charlottesville, VA, USA.
- Roger Williams Medical Center, Division of Surgical Oncology, Providence, RI, USA; Boston University Chobanian & Avedisian School of Medicine, Department of Surgery, Boston, MA, USA. Electronic address: psomasun@charter…
Zitieren
APA
Ganga, A., Kim, E. J., Mintzer, G. L., Adriance, W., Wang, R., Cholankeril, G., Balkrishnan, R., & Somasundar, P. S. (2023). Disparities in primary pancreatic adenocarcinoma survival by Medicaid-status: A national population-based risk analysis. European Journal of Surgical Oncology, 49(7), 1242-1249. https://doi.org/10.1016/j.ejso.2023.02.002
Vancouver
Ganga A, Kim EJ, Mintzer GL, Adriance W, Wang R, Cholankeril G, et al. Disparities in primary pancreatic adenocarcinoma survival by Medicaid-status: A national population-based risk analysis. European Journal of Surgical Oncology. 2023;49(7):1242-1249. doi:10.1016/j.ejso.2023.02.002
BibTeX
@article{Ganga2023,
author = {Ganga, Arjun and Kim, Eric J and Mintzer, Gabriel L and Adriance, William and Wang, Rachel and Cholankeril, George and Balkrishnan, Rajesh and Somasundar, Ponnandai S},
title = {Disparities in primary pancreatic adenocarcinoma survival by Medicaid-status: A national population-based risk analysis},
journal = {European Journal of Surgical Oncology},
year = {2023},
volume = {49},
number = {7},
pages = {1242--1249},
doi = {10.1016/j.ejso.2023.02.002}
}
EUVIMED